A Clinical Research Review Key Takeaways Persistent Corneal Epithelial Defects (PED) and corneal ulcers present complex...
Read More
Our mission is to advance the field of regenerative medicine by delivering high-quality HCT/P’s tissue allografts. We are committed to innovation, safety, and scientific integrity—providing healthcare professionals with products that align with regulatory standards and patient needs.
*Ponya Therapeutics is an FDA-registered and inspected HCT/P manufacturer that follows all relevant sections of the Code of Federal Regulations, including 21 CFR 1271, and adheres to Good Tissue Practices (GTP) and Good Manufacturing Practices (GMP).
Tunza® is a dehydrated amniotic membrane patch product derived from human placental tissue donated by healthy mothers who have undergone all FDA-required communicable disease testing. Tunza® is a sterile, protective wound covering available by prescription only.
Amono® is a dehydrated dual-layer amniotic membrane disk intended as a protective covering for ocular injuries and surgical sites. Amono® is sterile and available by prescription only.
Tunza® is a dehydrated amniotic membrane patch product derived from human placental tissue donated by healthy mothers who have undergone all FDA-required communicable disease testing. Tunza® is a sterile, protective wound covering available by prescription only.
Amono® is a dehydrated dual-layer amniotic membrane disk intended as a protective covering for ocular injuries and surgical sites. Amono® is sterile and available by prescription only.
Ponya Therapeutics is developing advanced products in regenerative medicine, integrating molecular biology, tissue engineering, and translational science to address physician and patient needs. Our portfolio includes cellular therapies and human cellular and tissue-based products (HCT/Ps).
A Clinical Research Review Key Takeaways Persistent Corneal Epithelial Defects (PED) and corneal ulcers present complex...
Read MoreA Clinical Research Review Key Takeaways In research, amniotic tissue provided a complex biological scaffold rich...
Read MoreKey Takeaways Patient selection for amniotic membrane allografts wound care requires consideration of wound duration, response...
Read More